Business
TGA proposes over-the-counter sales of CBD products – Small Caps
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
In a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Administration (TGA) has announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over the counter at pharmacies.
The TGAs provisional ruling entails the down-scheduling of low dose CBD products from Schedule 4 to Schedule 3 of the Poisons Standard. This means companies can apply to register their applicable products to be available through a pharmacist, without th…
-
Noosa News10 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News19 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
General23 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Noosa News20 hours agoQueensland government and nurses and midwives reach in-principle pay deal after months of negotiation